1
|
Al-Harithy RN and Al-Ghamdi S: Serum
resistin, adiposity and insulin resistance in Saudi women with type
2 diabetes mellitus. Ann Saudi Med. 25:283–287. 2005.PubMed/NCBI
|
2
|
Bauche IB, Ait El Mkadem S, Rezsohazy R,
Funahashi T, Maeda N, Miranda LM and Brichard SM: Adiponectin
downregulates its own production and the expression of its AdipoR2
receptor in transgenic mice. Biochem Biophys Res Commun.
345:1414–1424. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Yang Q, Graham TE, Mody N, Preitner F,
Peroni OD, Zabolotny JM, Kotani K, Quadro L and Kahn BB: Serum
retinol binding protein 4 contributes to insulin resistance in
obesity and type 2 diabetes. Nature. 436:356–362. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Graham TE, Yang Q, Bluher M, Hammarstedt
A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson P, Smith U
and Kahn BB: Retinol-binding protein 4 and insulin resistance in
lean, obese, and diabetic subjects. N Engl J Med. 354:2552–2563.
2006. View Article : Google Scholar : PubMed/NCBI
|
5
|
Stefan N, Hennige AM, Staiger H, Machann
J, Schick F, Schleicher E, Fritsche A and Häring HU: High
circulating retinol-binding protein 4 is associated with elevated
liver fat but not with total, subcutaneous, visceral, or
intramyocellular fat in humans. Diabetes Care. 30:1173–1178. 2007.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Cho YM, Youn BS, Lee H, Lee N, Min SS,
Kwak SH, Lee HK and Park KS: Plasma retinol-binding protein-4
concentrations are elevated in human subjects with impaired glucose
tolerance and type 2 diabetes. Diabetes Care. 29:2457–2461. 2006.
View Article : Google Scholar
|
7
|
Ribel-Madsen R, Friedrichsen M, Vaag A and
Poulsen P: Retinol-binding protein 4 in twins: regulatory
mechanisms and impact of circulating and tissue expression levels
on insulin secretion and action. Diabetes. 58:54–60. 2009.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Klöting N, Graham TE, Berndt J, Kralisch
S, Kovacs P, Wason CJ, Fasshauer M, Schön MR, Stumvoll M, Blüher M
and Kahn BB: Serum retinol-binding protein is more highly expressed
in visceral than in subcutaneous adipose tissue and is a marker of
intra-abdominal fat mass. Cell Metab. 6:79–87. 2007.PubMed/NCBI
|
9
|
Despres JP, Lamarche B, Mauriege P, Cantin
B, Dagenais GR, Moorjani S and Lupien PJ: Hyperinsulinemia as an
independent risk factor for ischemic heart disease. N Engl J Med.
334:952–957. 1996. View Article : Google Scholar : PubMed/NCBI
|
10
|
Pepe MG, Ginzton NH, Lee PD, Hintz RL and
Greenberg PL: Receptor binding and mitogenic effects of insulin and
insulin-like growth factors I and II for human myeloid leukemic
cells. J Cell Physiol. 133:219–227. 1987. View Article : Google Scholar : PubMed/NCBI
|
11
|
Faries PL, Rohan DI, Wyers MC, Marin ML,
Hollier LH, Quist WC and LoGerfo FW: Vascular smooth muscle cells
derived from atherosclerotic human arteries exhibit greater
adhesion, migration, and proliferation than venous cells. J Surg
Res. 104:22–28. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mahmoudi MJ, Mahmoudi M, Siassi F, Hedayat
M, Pasalar P, Chamari M, Abolhassani H, Rezaei N and Saboor-Yaraghi
AA: Circulating retinol-binding protein 4 concentrations in
patients with coronary artery disease and patients with type 2
diabetes mellitus. Int J Diabetes Dev Ctries. 32:105–110. 2012.
View Article : Google Scholar
|
13
|
Mallat Z, Simon T, Benessiano J, Clement
K, Taleb S, Wareham NJ, Luben R, Khaw KT, Tedgui A and Boekholdt
SM: Retinol-binding protein 4 and prediction of incident coronary
events in healthy men and women. J Clin Endocrinol Metab.
94:255–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Matsumoto K, Miyake S, Yano M, Ueki Y,
Yamaguchi Y, Akazawa S and Tominaga Y: Insulin resistance and
arteriosclerosis obliterans in patients with NIDDM. Diabetes Care.
20:1738–1743. 1997. View Article : Google Scholar : PubMed/NCBI
|
15
|
Giannattasio C and Mancia G: Arterial
distensibility in humans: modulating mechanisms, alterations in
diseases and effects of treatment. J Hypertens. 20:1889–1899. 2002.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Page C and Doubell AF: Mitogen-activated
protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem.
157:49–57. 1996. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pessin JE and Saltiel AR: Signaling
pathways in insulin action: molecular targets of insulin
resistance. J Clin Invest. 106:165–169. 2000. View Article : Google Scholar : PubMed/NCBI
|
18
|
Cusi K, Maezono K, Osman A, Pendergrass M,
Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR and Mandarino LJ:
Insulin resistance differentially affects the PI3-kinase- and MAP
kinase-mediated signaling in human muscle. J Clin Invest.
105:311–320. 2000. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Horvath CM: STAT proteins and
transcriptional responses to extracellular signals. Trends Biochem
Sci. 25:496–502. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Watanabe S, Mu W, Kahn A, Jing N, Li JH,
Lan HY, Nakagawa T, Ohashi R and Johnson RJ: Role of JAK/STAT
pathway in IL-6-induced activation of vascular smooth muscle cells.
Am J Nephrol. 24:387–392. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Guo F, Zarella C and Wagner WD: STAT4 and
the proliferation of artery smooth muscle cells in atherosclerosis.
Exp Mol Pathol. 81:15–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ost A, Danielsson A, Liden M, Eriksson U,
Nystrom FH and Stralfors P: Retinol-binding protein-4 attenuates
insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human
adipocytes. FASEB J. 21:3696–3704. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Takebayashi K, Sohma R, Aso Y and Inukai
T: Effects of retinol binding protein-4 on vascular endothelial
cells. Biochem Biophys Res Commun. 408:58–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Wang CC, Gurevich I and Draznin B: Insulin
affects vascular smooth muscle cell phenotype and migration via
distinct signaling pathways. Diabetes. 52:2562–2569. 2003.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Ingelsson E, Sundström J, Melhus H,
Michaëlsson K, Berne C, Vasan RS, Risérus U, Blomhoff R, Lind L and
Ärnlöv J: Circulating retinol-binding protein 4, cardiovascular
risk factors and prevalent cardiovascular disease in elderly.
Atherosclerosis. 206:239–244. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Bobbert T, Raila J, Schwarz F, Mai K,
Henze A, Pfeiffer AF, Schweigert FJ and Spranger J: Relation
between retinol, retinol-binding protein 4, transthyretin and
carotid intima media thickness. Atherosclerosis. 213:549–551. 2010.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Wu J, Shi YH, Niu DM, Li HQ, Zhang CN and
Wang JJ: Association among retinol-binding protein 4, small dense
LDL cholesterol and oxidized LDL levels in dyslipidemia subjects.
Clin Biochem. 45:619–622. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
von Eynatten M, Lepper PM, Liu D, Lang K,
Baumann M, Nawroth PP, Bierhaus A, Dugi KA, Heemann U, Allolio B
and Humpert PM: Retinol-binding protein 4 is associated with
components of the metabolic syndrome, but not with insulin
resistance, in men with type 2 diabetes or coronary artery disease.
Diabetologia. 50:1930–1937. 2007.
|
29
|
Cabré A, Lázaro I, Girona J, Manzanares J,
Marimón F, Plana N, Heras M and Masana L: Retinol-binding protein 4
as a plasma biomarker of renal dysfunction and cardiovascular
disease in type 2 diabetes. J Intern Med. 262:496–503.
2007.PubMed/NCBI
|
30
|
Neeli I, Liu ZM, Dronadula N, Ma ZA and
Rao GN: An essential role of the Jak-2/STAT-3/cytosolic
phospholipase A(2) axis in platelet-derived growth factor
BB-induced vascular smooth muscle cell motility. J Biol Chem.
279:46122–46128. 2004. View Article : Google Scholar : PubMed/NCBI
|
31
|
Sahar S, Dwarakanath RS, Reddy MA, Lanting
L, Todorov I and Natarajan R: Angiotensin II enhances
interleukin-18 mediated inflammatory gene expression in vascular
smooth muscle cells: a novel cross-talk in the pathogenesis of
atherosclerosis. Circ Res. 96:1064–1071. 2005. View Article : Google Scholar : PubMed/NCBI
|